Illuminare Biotechnologies is a privately held Delaware C-Corporation.
Illuminare-1 has been developed to date with substantial equity financing from Memorial Sloan Kettering, General Electric, family offices and angel investors.
Investment Inquiries
Accredited investors interested in learning more about Illuminare should contact Illuminare CEO, Brian Longstreet.